Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer.

Chen, Dong-liang; Wang, Zhi-qiang; Ren, Chao; Zeng, Zhao-lei; Wang, De-shen; Luo, Hui-yan; Wang, Feng; Qiu, Miao-zhen; Bai, Long; Zhang, Dong-sheng; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua

Chen, Dong-liang; Wang, Zhi-qiang; Ren, Chao; Zeng, Zhao-lei; Wang, De-shen; Luo, Hui-yan; Wang, Feng; Qiu, Miao-zhen; Bai, Long; Zhang, Dong-sheng; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua.

Affiliation

Xu RH; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Dong Feng East Road, 510060 Guangzhou, P,R, China. xurh@sysucc.org.cn.

J Transl Med ; 11: 277, 2013 Nov 02.

Article in En | MEDLINE | ID: mdl-24180516

Subject(s)

Paxillin/metabolism; Stomach Neoplasms/metabolism; Survival Rate; Adult; Aged; Base Sequence; Blotting, Western; Cell Line, Tumor; DNA Primers; Disease Progression; Female; Humans; Male; Middle Aged; Real-Time Polymerase Chain Reaction; Stomach Neoplasms/pathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Survival Rate / Paxillin Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Transl Med Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google